ReviewCancers2022
Overcoming Resistance to HER2-Directed Therapies in Breast Cancer.
Ilana Schlam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
this papertrialcites it
ReviewCancers2022
Ilana Schlam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.